Brind.

Novartis and Cipla are key players in the ARDS market.

1 report, 1 independent Updated Sep 4

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Novartis Cipla

Keep exploring

The entities involved

Novartis
Swiss-American multinational pharmaceutical corporation
- Novartis acquired Avidity in a $12 billion purchase, while Trump simultaneously threatened Swiss businesses with tariffs.Sat 01:46
- GSK and Novartis are identified as major pharmaceutical companies.Fri 02:16
Cipla
Indian multi-national pharmaceutical and biotechnology company

Nothing else this week.

Related events

Novartis operated through a wholly owned subsidiary in India on July 1, 2026.Jul 30

Coverage

Newest first; wire copies grouped

Sep 4GlobeNewswireAcute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva The Ac